|
ZBTB5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10539999999848E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559160E-01 |
| Normal-vs-Stage2 |
6.787700E-02 |
| Normal-vs-Stage3 |
5.81159997903313E-09 |
| Normal-vs-Stage4 |
2.95700000041421E-07 |
| Stage1-vs-Stage2 |
3.821200E-01 |
| Stage1-vs-Stage3 |
1.68430000002662E-06 |
| Stage1-vs-Stage4 |
1.417590E-04 |
| Stage2-vs-Stage3 |
1.630270E-02 |
| Stage2-vs-Stage4 |
2.559800E-02 |
| Stage3-vs-Stage4 |
9.363800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97076999999268E-05 |
| Normal-vs-AfricanAmerican |
1.850600E-01 |
| Normal-vs-Asian |
8.476800E-01 |
| Caucasian-vs-AfricanAmerican |
2.432600E-01 |
| Caucasian-vs-Asian |
4.228800E-01 |
| AfricanAmerican-vs-Asian |
7.353600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89740000045013E-07 |
| Normal-vs-Female |
2.044600E-01 |
| Male-vs-Female |
2.989100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.271850E-02 |
| Normal-vs-Age(41-60Yrs) |
8.841900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.58257999999245E-05 |
| Normal-vs-Age(81-100Yrs) |
2.916800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.328600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.725000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.641200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.207800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.327200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.265800E-01 |
| Normal-vs-Grade 2 |
3.320800E-01 |
| Normal-vs-Grade 3 |
9.37679999979402E-07 |
| Normal-vs-Grade 4 |
3.5120018004875E-11 |
| Grade 1-vs-Grade 2 |
1.379960E-01 |
| Grade 1-vs-Grade 3 |
2.119900E-03 |
| Grade 1-vs-Grade 4 |
1.52219999999259E-05 |
| Grade 2-vs-Grade 3 |
1.566160E-04 |
| Grade 2-vs-Grade 4 |
1.98689997787938E-09 |
| Grade 3-vs-Grade 4 |
1.698030E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.657400E-01 |
| Normal-vs-ccB subtype |
9.20730158782135E-12 |
| ccA subtype-vs-ccB subtype |
8.77076189453874E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.215000E-03 |
| Normal-vs-N1 |
4.87160000006703E-07 |
| N0-vs-N1 |
1.919200E-03 |
|
|
